GeneDx Holdings Corp. - Class A Common Stock (WGS)

89.61
0.00 (0.00%)

GeneDx Holdings Corp

is a genomics company that specializes in providing genetic testing services to aid in the diagnosis and treatment of various genetic disorders. By leveraging advanced genomic technologies and bioinformatics, the company aims to deliver accurate and comprehensive genetic information that helps clinicians make informed decisions about patient care. GeneDx focuses on enhancing the understanding of rare and hereditary diseases, facilitating personalized medicine, and improving patient outcomes through insightful genomic data services.

SummaryNewsPress ReleasesChartHistoricalFAQ
IBD 50's GeneDx Surges On FDA Recommendations For AI Device Developmentinvestors.com
GeneDx provides whole and exome gene sequencing to identify rare diseases.
Via Investor's Business Daily · January 6, 2025
Focus On High Cash Flow Companies. You Are The Company You Keep.talkmarkets.com
There are too many stocks acting well to expect a bear market right now.
Via Talk Markets · January 5, 2025
Meta Stock, Energy Plays Lead Five Leaders Rebounding Bullishlyinvestors.com
Energy plays, a biotech and a brokerage also are flashing buy signals or setting up.
Via Investor's Business Daily · January 4, 2025
Resources Connection, SPS Commerce And 3 Stocks To Watch Heading Into Fridaybenzinga.com
US stock futures up, GeneDx appoints new COO, Lifecore beats expectations, SPS Commerce acquires Carbon6, Resources Connection & UDR report strong quarters.
Via Benzinga · January 3, 2025
Best Performing Stocks Of 2024talkmarkets.com
A look at the some of best performing stocks in 2024 of current Russell 3,000 members. 
Via Talk Markets · January 2, 2025
Why NASDAQ:WGS qualifies as a high growth stock.chartmill.com
Why the high growth investor may take a look at GENEDX HOLDINGS CORP (NASDAQWGS).
Via Chartmill · December 11, 2024
The Analyst Verdict: GeneDx Hldgs In The Eyes Of 6 Expertsbenzinga.com
Via Benzinga · October 16, 2024
GeneDx Stock Rocketed 1310% In Dramatic Turnaround Powered By DNA Analyticsinvestors.com
The company provides sequencing tools to help diagnose children with rare diseases.
Via Investor's Business Daily · September 19, 2024
The Top 5 Mid Cap Stocks Of 2024talkmarkets.com
These high-fliers are on the leading edge of innovation.
Via Talk Markets · December 19, 2024
Meet the Healthcare Stock That Produced Nvidia-Sized Gains in Less Than a Yearfool.com
Via The Motley Fool · November 16, 2024
Don’t Confuse Brains With A Bull Market, Or Price With Valuetalkmarkets.com
If you are interested in the stock market, maybe it is time to stop focusing on The Fed.
Via Talk Markets · November 10, 2024
Apple Satellite Connectivity Provider Globalstar And Timberland Parent V.F Corp Are Among Top 7 Mid Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio?benzinga.com
Top mid-cap stock performers: MDGL (+51.70%), PRCT (+34.20%), GSAT (+33.98%), WGS (+31.17%), NXT (+25.91%), VFC (+25.82%), OMCL (+23.22%).
Via Benzinga · November 3, 2024
Gold Gains 1%; Phillips 66 Shares Fall After Q3 Resultsbenzinga.com
Via Benzinga · October 29, 2024
Expert Ratings For GeneDx Hldgsbenzinga.com
Via Benzinga · July 17, 2024
The Latest Analyst Ratings For GeneDx Hldgsbenzinga.com
Via Benzinga · June 26, 2024
Nasdaq Surges Over 100 Points; Pfizer Earnings Top Viewsbenzinga.com
Via Benzinga · October 29, 2024
12 Health Care Stocks Moving In Tuesday's Intraday Sessionbenzinga.com
Via Benzinga · October 29, 2024
Genetic Testing Firm GeneDx Reports Narrower Q3 Loss As Revenues Surge, Lifts Annual Guidancebenzinga.com
GeneDx stock rises as Q3 results beat expectations with EPS loss improvement, 44% revenue growth to $76.87M, and 77% increase in test revenue.
Via Benzinga · October 29, 2024
Corning Posts Upbeat Q3 Earnings, Joins Opera, Inari Medical, Incyte And Other Big Stocks Moving Higher On Tuesdaybenzinga.com
Via Benzinga · October 29, 2024
The Markets Are Ignoring Risk, But That Does Not Mean You Should...talkmarkets.com
It is Fall clean-up time. Sell lagging and sagging companies.
Via Talk Markets · September 29, 2024
WGS Stock Earnings: GeneDx Hldgs Beats EPS, Beats Revenue for Q2 2024investorplace.com
WGS stock results show that GeneDx Hldgs beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · July 30, 2024
GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testingbenzinga.com
GeneDx Holdings Corp. (NASDAQWGS) has soared 1,101% this year, attributed to its mix shift towards exome/genome testing and record high margins.
Via Benzinga · July 18, 2024
7 Small-Cap Stocks With Massive Potential Returnsinvestorplace.com
Explore these small-cap stocks with high potential in health care, REITs, entertainment, hardware, finance, and distribution industries.
Via InvestorPlace · July 6, 2024
Over $12M Bet On PBF Energy? Check Out These 3 Stocks Insiders Are Buyingbenzinga.com
Via Benzinga · June 6, 2024
Over $4M Bet On ProFrac Holding? Check Out These 3 Stocks Insiders Are Buyingbenzinga.com
Via Benzinga · May 29, 2024